Feb 05, 2024 / 01:00PM GMT
Operator
Ladies and gentlemen, good day and welcome to the Q3 FY '24 earnings conference call of Suven Pharmaceuticals Limited. Before we begin, I would like to state that some of the statements made in today's discussion may be forward-looking in nature and may involve risks and uncertainties. A detailed statement in this regard is available in the results presentation that was sent to you earlier. As a reminder, all participant lines will be in the listen-only mode.
There will be an opportunity for you to ask questions after the presentation concludes. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Ms. Cyndrella Carvalho, Head of Investor Relations from Suven Pharmaceuticals Limited. Thank you. Over to you, ma'am.
Cyndrella Carvalho - Suven Pharmaceuticals Limited - IR
Good evening, everyone, and a warm welcome to you all on Suven Pharma's Q3 FY '24 earnings call. Let me introduce you to our management team present here with us today: we have our Executive Chairman, Mr. Annaswamy Vaidheesh; our
Q3 2024 Suven Pharmaceuticals Ltd Earnings Call Transcript
Feb 05, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers